Chiral Technologies, part of Daicel Corporation, a provider of enantioselective chromatography products, has acquired the assets of Diffinity Genomics of West Henrietta, New York. Diffinity Genomics has developedl technology for the purification of nucleic acids, which formed the foundation for their products in DNA purification markets. The Diffinity RapidTip technology provides a method for rapid purification of amplified DNA fragments from polymerase chain reaction (PCR) in a single step.

Upon the successful completion of the acquisition, Joseph Marasco, PHD., current CEO of Diffinity Genomicswill leave Diffinity Genomics to pursue other interests.

Source: Chiral Technologies